购物车
全部删除
您的购物车当前为空
KRAS IN-44 (Compound S2C2M2) 是一种用于降解PDE6D的试剂。它能够抑制PDE6D依赖性的KRAS转运及其下游信号通路,并下调EGF诱导的PI3K、AKT和mTOR的磷酸化。KRAS IN-44 还可以促进凋亡 (Apoptosis) 并对肝母细胞瘤显示出抗肿瘤活性。
KRAS IN-44 (Compound S2C2M2) 是一种用于降解PDE6D的试剂。它能够抑制PDE6D依赖性的KRAS转运及其下游信号通路,并下调EGF诱导的PI3K、AKT和mTOR的磷酸化。KRAS IN-44 还可以促进凋亡 (Apoptosis) 并对肝母细胞瘤显示出抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
KRAS IN-44 相关产品
| 产品描述 | KRAS IN-44 (Compound S2C2M2) is a PDE6D degrader. It inhibits PDE6D-dependent KRAS transport and downstream signaling pathways. Additionally, KRAS IN-44 downregulates EGF-induced phosphorylation of PI3K, AKT, and mTOR. It promotes apoptosis and exhibits antitumor activity against hepatoblastoma. |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容